Committed to sharing our science

Committed to sharing our science

335 results available

Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM

Journal of the American College of Cardiology

Masri, A et al

October 28, 2024
Payer Differences on Costs of Care in Obstructive Hypertrophic Cardiomyopathy

Poster, AMCP Nexus 2024

Reza, N et al

October 15, 2024
Fast Skeletal Muscle Troponin Activator CK-4015089 Improves Muscle Function in a FSHD Mouse Model with Muscle Weakness

Poster, European Muscle Conference 2024

Hwee, DT et al

Ljubljana, Slovenia

September 22, 2024
Cytochrome P450 (CYP) Phenotyping of Aficamten, a Next-in-class Inhibitor of Cardiac Myosin, Using Human Liver Microsomes and Human Recombinant CYP Enzymes

Poster, ISSX/JSSX 2024

Sukhun, R et al

September 15, 2024
Qualitative Interview Study of Patient-reported Symptoms, Impacts and Treatment Goals of Patients With Obstructive Hypertrophic Cardiomyopathy

BMJ Open

Shore, S et al

September 17, 2024